Pacira BioSciences' Retained Earnings rose 963.95% to -$201.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$201.0 million, marking a year-over-year increase of 963.95%. This contributed to the annual value of -$206.4 million for FY2024, which is 9322.45% down from last year.
Latest data reveals that Pacira BioSciences reported Retained Earnings of -$201.0 million as of Q3 2025, which was up 963.95% from -$206.4 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Retained Earnings registered a high of -$78.9 million during Q2 2024, and its lowest value of -$243.5 million during Q1 2021.
Its 5-year average for Retained Earnings is -$170.2 million, with a median of -$168.3 million in 2023.
As far as peak fluctuations go, Pacira BioSciences' Retained Earnings surged by 4461.92% in 2024, and later plummeted by 16148.28% in 2025.
Pacira BioSciences' Retained Earnings (Quarter) stood at -$211.9 million in 2021, then rose by 29.8% to -$148.8 million in 2022, then increased by 28.2% to -$106.8 million in 2023, then plummeted by 93.22% to -$206.4 million in 2024, then increased by 2.62% to -$201.0 million in 2025.
Its Retained Earnings stands at -$201.0 million for Q3 2025, versus -$206.4 million for Q2 2025 and -$201.5 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value